| Current state of renal transplant immunosuppression: Present and future HV Kalluri, KL Hardinger World journal of transplantation 2 (4), 51, 2012 | 113 | 2012 |
| An evidence-based recommendation to increase the dosing frequency of buprenorphine during pregnancy SN Caritis, JR Bastian, H Zhang, H Kalluri, D English, M England, ... American journal of obstetrics and gynecology 217 (4), 459. e1-459. e6, 2017 | 60 | 2017 |
| Glecaprevir–pibrentasvir to treat chronic hepatitis C virus infection in Asia: two multicentre, phase 3 studies—a randomised, double-blind study (VOYAGE-1) and an open-label … L Wei, G Wang, NN Alami, W Xie, J Heo, Q Xie, M Zhang, YJ Kim, SG Lim, ... The lancet Gastroenterology & hepatology 5 (9), 839-849, 2020 | 44 | 2020 |
| A physiologically based pharmacokinetic modelling approach to predict buprenorphine pharmacokinetics following intravenous and sublingual administration HV Kalluri, H Zhang, SN Caritis, R Venkataramanan British journal of clinical pharmacology 83 (11), 2458-2473, 2017 | 33 | 2017 |
| Tilavonemab in early Alzheimer’s disease: results from a phase 2, randomized, double-blind study H Florian, D Wang, SE Arnold, M Boada, Q Guo, Z Jin, H Zheng, ... Brain 146 (6), 2275-2284, 2023 | 32 | 2023 |
| Gestational changes in buprenorphine exposure: A physiologically‐based pharmacokinetic analysis H Zhang, HV Kalluri, JR Bastian, H Chen, A Alshabi, SN Caritis, ... British journal of clinical pharmacology 84 (9), 2075-2087, 2018 | 30 | 2018 |
| Low vitamin D exposure is associated with higher risk of infection in renal transplant recipients HV Kalluri, LM Sacha, AI Ingemi, MA Shullo, HJ Johnson, P Sood, ... Clinical transplantation 31 (5), e12955, 2017 | 18 | 2017 |
| Coproporphyrin I can serve as an endogenous biomarker for OATP1B1 inhibition: assessment using a Glecaprevir/Pibrentasvir clinical study HV Kalluri, R Kikuchi, S Coppola, J Schmidt, MEF Mohamed, DAJ Bow, ... Clinical and Translational Science 14 (1), 373-381, 2021 | 17 | 2021 |
| Phase 1 Evaluation of Elezanumab (Anti–Repulsive Guidance Molecule A Monoclonal Antibody) in Healthy and Multiple Sclerosis Participants HV Kalluri, MR Rosebraugh, TP Misko, A Ziemann, W Liu, BAC Cree Annals of neurology 93 (2), 285-296, 2023 | 6 | 2023 |
| Cariprazine in pediatric patients with autism spectrum disorder: results of a pharmacokinetic, safety and tolerability study PP Yeung, KA Johnson, R Riesenberg, A Orejudos, T Riccobene, ... Journal of Child and Adolescent Psychopharmacology 33 (6), 232-242, 2023 | 4 | 2023 |
| Phase 1 Evaluation of Elezanumab (anti-RGMa mAb) in Healthy and MS Participants. HV Kalluri, MR Rosebraugh, TP Misko, A Ziemann, W Liu, BAC Cree Annals of Neurology, 2022 | 2 | 2022 |
| Randomized, placebo-controlled single ascending dose study to evaluate the safety, tolerability, pharmacokinetics, and immunogenicity of ABBV-0805, an anti-alpha-synuclein … H Kalluri, C Zadikoff, L Rueter, O Graff, H Xiong MOVEMENT DISORDERS 36, S179-S179, 2021 | 2 | 2021 |
| Levodopa‐carbidopa intestinal gel high concentration formulation is clinically bioequivalent to commercial formulation M Rosebraugh, HV Kalluri, W Liu, C Locke, D Sidhu, JH Han, J Benesh Pharmacology Research & Perspectives 7 (2), e00473, 2019 | 2 | 2019 |
| Current state of renal transplant immunosuppression: Present and future. World J Transplant 2012; 2 (4): 51-68 HV Kalluri, KL Hardinger | 2 | |
| Current state of renal transplant immunosuppression: Present and future. World J Transplant. 2012; 2 (4): 51. doi: 10.5500/wjt. v2. i4. 51.» HV Kalluri, KL Hardinger | 2 | |
| Safety, Tolerability, and Pharmacokinetics of Cariprazine in Pediatric Patients With ASD P Yeung, KA Johnson, R Riesenberg, A Orejudos, T Riccobene, ... AACAP/CACAP 2022 Annual Meeting, 2022 | 1 | 2022 |
| Evaluation of Renal Anionic Secretion Following Living-donor and Deceased-donor Renal Transplantation: A Clinical Pharmacokinetic Study of Cefoxitin Microdosing HV Kalluri, P Sood, W Zhao, PS Randhawa, AD Tevar, S Hariharan, ... Transplantation Direct 6 (6), e561, 2020 | 1 | 2020 |
| Computational predictions of mycophenolic acid exposure after oral administration using a joined in vitro–in vivo extrapolation and physiologically-based pharmacokinetic … R Joshi, R Venkataramanan, HV Kalluri Transplantation 101 (5S-3), S13-S14, 2017 | 1 | 2017 |
| Comparability of Elezanumab Safety, Tolerability, and Pharmacokinetics in Healthy Japanese, Chinese, and White Participants HV Kalluri, MR Rosebraugh, N Boehm, C Locke, A Ziemann, H Xiong Clinical Pharmacology in Drug Development 13 (2), 180-189, 2024 | | 2024 |
| Pharmacokinetics, Tolerability, and Safety of Glecaprevir/Pibrentasvir Co‐formulated Bilayer Tablet Following Repeated Administration in Healthy Chinese Adults HV Kalluri, RK Oberoi, Q Chen, Q Jiang, A Asatryan, NN Alami, C Yu, ... Clinical Pharmacology in Drug Development 12 (10), 945-955, 2023 | | 2023 |
